• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Industry

Listed private equity recovery underway

Stuart Howard of HarbourVest
  • John Bakie
  • 07 June 2012
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Subjected to unstable public markets since the 2008 crisis, many quoted vehicles have seen their value fall. John Bakie investigates if this may change soon.

The recent past has been tough for private equity's listed funds. Subjected to the full force of public markets during the fallout of the financial crisis, many vehicles have seen progressively dwindling share prices and deepening discounts.

Stuart Howard, chief operating officer (COO) of European listed products at HarbourVest, and a 3i veteran, believes this may end soon, saying the tide is turning for listed private equity. While funds suffered in the wake of Lehman Brothers¹ collapse, the recovery is now beginning. "HVPE (HarbourVest Global Private Equity) listed in 2007, and while net asset value (NAV) has climbed some 35%, shares slipped from a starting price of $10 down to around $5. Now they are starting to recover and are trading nearer to $7," he explains.

Howard believes the key to reducing the discount gap and improving investor interest in listed private equity is better communication by the industry. "Private equity has been very private and not open enough, but we need to explain this distinct asset class to investors," he says.

Public market investors may be getting over their fear of the asset class

Since joining HarbourVest in January, Howard has held some 80 meetings with investors, brokers, journalists and trade bodies to further the message about what listed private equity is and how it can benefit a portfolio.

Listed Private Equity's (LPEQ) Ross Butler agrees with Howard's strategy of educating investors: "We're dedicated to raising awareness of private equity in listed markets, and we have made a lot of progress in this area since LPEQ was founded in 2006." Confusion about what listed private equity is, and how it differs from other alternative assets, can be a key barrier to investment. "I have spent a lot of time explaining to investors that private equity is not overvalued, and it's not all about fees on top of fees," says Howard. Many investors naturally tend to compare private equity to hedge funds, but Howard says they often fail to realise that fee structures are largely the same and the private equity model makes returns in a very different way to a hedge fund. "Debunking myths is a key part of what we are doing," he adds.

Investors may also be put off by the poor performance of a number of funds following the financial crisis. As the Five-year %NAV performance table (see below) shows, some of the biggest post-crisis names in listed private equity have seen NAV collapse since 2007. These high-profile cases will have spooked many investors and have led to discounts widening to 60% or more at the bottom of the market.

Five-year NAV performance

However, with discounts starting to close, many public market investors may be getting over their fear of the asset class. Jock Green-Armytage, part of JZ Capital Partners¹ (JZCP) European team, says: "The large discount is largely the result of an overreaction to some poorly performing, iconic funds. Investors are starting to realise that many of the funds that did badly were over-committed and under-resourced when the crisis hit, which is not the case for many other funds." Talk alone is not enough to convince investors; listed funds also need to demonstrate that they can return money to investors. Deep discounts to NAV seen after the collapse of Lehman Brothers could be beneficial to investors.

"The discount to NAV has widened dramatically. Having historically sat at a percentage discount in the mid-teens, today funds are trading at an average discount of more than 30%, and listed private equity has not seen a recovery in line with the rest of the stock market," says Butler. While this may have caused concern among investors, it also offers them the chance to obtain shares at a deep discount and benefit from significant uplift over the long-term.

However, for some public-market investors, the prospect of distant capital gains may be less tempting that obtaining significant yield. "There's a pretty big focus on yield in the investment world at the moment," Butler says.

Show me the dividend
Some listed funds are already exploring options to pay dividends on a more regular basis. F&C Private Equity recently announced it would seek to do so, equivalent to 4% of NAV. The news was met with a sudden rise in the fund¹s share price and reduction in its discount, though it is unclear whether this change was due to good performance figures or the revised dividend offer.

In May, JZCP followed in F&C's footsteps, announcing it would pay a dividend calculated at 3% of NAV per annum, representing a yield at discount of approximately 5% (based on 16 May share prices). This too was met with an increase in share price and closing of the discount gap.

Green-Armytage says: "[The dividend] does have an effect on investor sentiment. At our current share price, this is equivalent to a 5% yield, which is difficult to get at the moment." David Macfarlane, chairman of JZCP, adds: "For investors, being paid an income while you wait until you can realise your capital increase is an attractive prospect." However, despite investor appetite for yield at the moment, listed private equity is, and will remain, an asset class that is primarily focused on capital growth over income, and those investing should expect a long-term commitment.

"There are a number of funds now looking at dividend payments as a method of discount control," says Butler, "but those investing in listed private equity should be focused on the potential for capital gain." Green-Armytage agrees that capital growth is still the primary driver in private equity investment: "The dividend is a good way of smoothing out the discount but will not close the gap on its own."

Figures from LPX (below) show how listed private equity funds have, over the long-term, significantly outperformed other benchmarks, and with many funds currently selling at a discount of around 30%, there are significant opportunities for uplift over and above the achievement of NAV. With a number of funds now seeing exits in their underlying portfolios, listed funds will be hopeful investors will start to come on board again as they see funds demonstrate the real value being created in their portfolios.

Total return performance to 20 April 2012

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Industry
  • Funds
  • UK / Ireland
  • DACH
  • France
  • Southern Europe
  • Benelux
  • Nordics
  • HarbourVest
  • LPEQ
  • JZ Capital Partners

More on Industry

EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
EU foreign subsidies regulations
EU FSR could impact PE fundraising with potential rise in ‘clean funds’

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
Jan Cerny of BHM Group
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • Investments
  • 01 September 2023
Bettina Curtze of Redalpine
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013